Logo image of CLYM

CLIMB BIO INC (CLYM) Stock Analyst Ratings

NASDAQ:CLYM - US28658R1068 - Common Stock

2.23 USD
-0.07 (-3.04%)
Last: 8/29/2025, 8:13:46 PM
2.2 USD
-0.03 (-1.35%)
After Hours: 8/29/2025, 8:13:46 PM
Buy % Consensus

88

ChartMill assigns a Buy % Consensus number of 88% to CLYM. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 9.18. This target is 311.66% above the current price.
CLYM was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about CLYM.
In the previous month the buy percentage consensus was at a similar level.
CLYM was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

CLYM Historical Analyst RatingsCLYM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 2.237.079.699.1810.50 - 217.04% 334.53% 311.66% 370.85%

Related screens

CLYM Current Analyst RatingCLYM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-08-15 Baird Initiate Outperform
2025-06-06 Oppenheimer Initiate Outperform